ANKYLOSING SPONDYLITIS

You have access
Monitoring of Disease Activity With a Smartphone App in Routine Clinical Care in Patients With Axial Spondyloarthritis
Robin Kempin, Jutta G. Richter, Anna Schlegel, Xenofon Baraliakos, Styliani Tsiami, Bjoern Buehring, David Kiefer, Juergen Braun and Uta Kiltz

The Journal of Rheumatology August 1 2022, 49 (8) 878-884; DOI: https://doi.org/10.3899/jrheum.211116
You have access
Central Obesity in Axial Spondyloarthritis: The Missing Link to Understanding Worse Outcomes in Women?
Sinead Maguire, Fiona Wilson, Phil Gallagher and Finbar O’Shea

The Journal of Rheumatology June 1 2022, 49 (6) 577-584; DOI: https://doi.org/10.3899/jrheum.211062
You have access
Understanding the Disease Burden of Unemployed Patients With Axial Spondyloarthritis: Results From the Spanish Atlas 2017
Marco Garrido-Cumbrera, Eduardo Collantes-Estevez, Victoria Navarro-Compán, Pedro Zarco-Montejo, Carlos Sastre, José Correa-Fernández, Sergio Sanz-Gómez, Pedro Plazuelo-Ramos and Jordi Gratacos

The Journal of Rheumatology April 1 2022, 49 (4) 373-379; DOI: https://doi.org/10.3899/jrheum.210655
Open Access
Spinal Radiographic Progression and Predictors of Progression in Patients With Radiographic Axial Spondyloarthritis Receiving Ixekizumab Over 2 Years
Désirée van der Heijde, Mikkel Østergaard, John D. Reveille, Xenofon Baraliakos, Andris Kronbergs, David M. Sandoval, Xiaoqi Li, Hilde Carlier, David H. Adams and Walter P. Maksymowych

The Journal of Rheumatology March 1 2022, 49 (3) 265-273; DOI: https://doi.org/10.3899/jrheum.210471
You have access
The Association of Tumor Necrosis Factor Inhibitor Use With Incident Hypertension in Ankylosing Spondylitis: Data From the PSOAS Cohort
Jean W. Liew, S. Reza Jafarzadeh, Maureen Dubreuil, Susan R. Heckbert, Stephen J. Mooney, Matthew A. Brown, Mariko L. Ishimori, John D. Reveille, Michael M. Ward, Michael H. Weisman and Lianne S. Gensler

The Journal of Rheumatology March 1 2022, 49 (3) 274-280; DOI: https://doi.org/10.3899/jrheum.210332
You have access
Persistence to Biologic Therapy Among Patients With Ankylosing Spondylitis: An Observational Study Using the OPAL Dataset
Hedley Griffiths, Tegan Smith, Christopher Mack, Jo Leadbetter, Belinda Butcher, Mustafa Acar and Sabina Ciciriello

The Journal of Rheumatology February 1 2022, 49 (2) 150-156; DOI: https://doi.org/10.3899/jrheum.201551
You have access
Extraskeletal Manifestations in Axial Spondyloarthritis Are Associated With Worse Clinical Outcomes Despite the Use of Tumor Necrosis Factor Inhibitor Therapy
Rienk van der Meer, Suzanne Arends, Sandra Kruidhof, Reinhard Bos, Hendrika Bootsma, Freke Wink and Anneke Spoorenberg

The Journal of Rheumatology February 1 2022, 49 (2) 157-164; DOI: https://doi.org/10.3899/jrheum.210308
Open Access
The Interplay Between COVID-19 and Spondyloarthritis or Its Treatment
James T. Rosenbaum, Michael H. Weisman, Hedley Hamilton, Cassie Shafer, Elin Aslanyan, Richard A. Howard, Kimberly Ogle, John D. Reveille, Kevin L. Winthrop and Dongseok Choi

The Journal of Rheumatology February 1 2022, 49 (2) 225-229; DOI: https://doi.org/10.3899/jrheum.210742
Open Access
Risk Factors for Diagnosis of Psoriatic Arthritis, Psoriasis, Rheumatoid Arthritis, and Ankylosing Spondylitis: A Set of Parallel Case-control Studies
Elana Meer, Telma Thrastardottir, Xingmei Wang, Maureen Dubreuil, Yong Chen, Joel M. Gelfand, Thorvardur J. Love and Alexis Ogdie

The Journal of Rheumatology January 1 2022, 49 (1) 53-59; DOI: https://doi.org/10.3899/jrheum.210006
You have access
Domains to Be Considered for the Core Outcome Set of Axial Spondyloarthritis: Results From a 3-round Delphi Survey
Anne Boel, Victoria Navarro-Compán, Annelies Boonen, Philip Mease, Uta Kiltz, Maxime Dougados, Robert Landewé and Désirée van der Heijde

The Journal of Rheumatology December 1 2021, 48 (12) 1810-1814; DOI: https://doi.org/10.3899/jrheum.210206

Main menu

User menu

Search

ANKYLOSING SPONDYLITIS

Pages

Content

Resources

Subscribers

More